3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
13
Lymphoma, Large B-Cell, Diffuse
12
Burkitt Lymphoma
12
Lymphoma, Follicular
8
Lymphoma, Non-Hodgkin
6
Lymphoma
6
Neoplasms
5
Prostatic Neoplasms, Castration-Resistant
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, B-Cell
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leukemia
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Plasmablastic Lymphoma
2
Lymphoproliferative Disorders
2
Lymphoma, T-Cell
2
Lymphoma, B-Cell, Marginal Zone
2
Triple Negative Breast Neoplasms
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Multi-centric Castleman's Disease
1
Metastatic Castration-sensitive Prostate Cancer
1
Metastatic Castration-resistant Prostate Neoplasms
1
Macular dystrophy, corneal type 1
1
Lymphoma, Mantle-Cell
1
Lymphadenopathy
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Leukemia, Hairy Cell
1
Interventions
obinutuzumab
1
glofitamab
1
fludarabine phosphate
1
Whole-Body Irradiation
1
Tacrolimus
1
Sirolimus
1
Peripheral Blood Stem Cell Transplantation
1
Mycophenolic Acid
1
Methotrexate
1
Melphalan
1
Etoposide
1
Cyclosporine
1
Cyclophosphamide
1
Busulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Dendritic Cell Sarcoma, Interdigitating
×
Prednisone
×
30 days
×
Clear all
No trials found.